<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="32604" end="32611" sStart="32443" offset="161" sid="r8.suggest.v.0585" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="It will be of interest to find out whether the cumulative prevalence of specific autoantibody subsets tends to increase over time, as this would suggest that the mechanisms underlying the development of these reactivities continue to evolve over the course of the arthropathy." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="27189" end="27197" sStart="null" offset="41" sid="r8.suggest.v.0972" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="This modest level of sensitivity suggests that testing for this spectrum of autoantibodies carries little advantages over RF alone in diagnosing early RA." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="27364" end="27374" sStart="null" offset="29" sid="r8.suggest.v.0644" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="This study provides evidence suggesting that anti-Sa anti-bodies appear to be a marker for a subset of early RA patients whose disease may be more severe and erosive." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/ar93.anc" start="25106" end="25111" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="carichter" text="A cohort of patients with synovitis of recent onset was evaluated and we sought to determine the prevalence and potential clinical utility of a spectrum of autoantibodies that has been &lt;b&gt;shown&lt;/b&gt; to be associated with RA." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="27643" end="27649" sStart="null" offset="117" sid="r11.severe.j.0451" wn="1" wnkey="severe%5:00:00:intense:00" annotator="vebatchelder" text="These data are consistent with observations in a French RA cohort, where anti-Sa and SE were associated with severe radiographic erosions [ 9]." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="12678" end="12684" sStart="null" offset="61" sid="r11.severe.j.0448" wn="1" wnkey="severe%5:00:00:intense:00" annotator="vebatchelder" text="Anti-Sa identifies a subset of male RA patients with severe disease." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="23373" end="23379" sStart="null" offset="84" sid="r11.severe.j.0449" wn="1" wnkey="severe%5:00:00:intense:00" annotator="anfahmy" text="Anti-Sa antibodies identify a male predominant subset of RA patients with severe disease" />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="29044" end="29050" sStart="null" offset="90" sid="r11.severe.j.0034" wn="1" wnkey="severe%5:00:00:intense:00" annotator="anfahmy" text="The finding that anti-Sa antibodies are associated both with male gender and with severe early RA further emphasizes the importance of gender differences in the clinical expression of this heterogeneous disease." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="27498" end="27504" sStart="null" offset="163" sid="r11.severe.j.0450" wn="5" wnkey="severe%5:00:00:critical:03" annotator="adelpriore" text="This study provides evidence suggesting that anti-Sa anti-bodies appear to be a marker for a subset of early RA patients whose disease may be more severe and erosive." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="7593" end="7599" sStart="null" offset="166" sid="r11.severe.j.0447" wn="5" wnkey="severe%5:00:00:critical:03" annotator="adelpriore" text="This study provides evidence suggesting that anti-Sa antibodies appear to be a marker for a subset of early RA patients whose disease may be more severe and erosive." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="29044" end="29050" sStart="null" offset="90" sid="r11.severe.j.0034" wn="6" wnkey="severe%5:00:01:bad:00" annotator="adelpriore" text="The finding that anti-Sa antibodies are associated both with male gender and with severe early RA further emphasizes the importance of gender differences in the clinical expression of this heterogeneous disease." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="28208" end="28218" sStart="null" offset="3" sid="r10.particular.j.0695" wn="2147483647" wnkey="null" annotator="cgozo" text="In particular, there was a significantly higher prevalence of radiographic erosions in the anti-Sa-positive RA patients compared with the rest of the RA population, despite the fact that the anti-Sa-positive patients had received significantly higher doses of prednisone and more disease modifying antirheumatic drug therapy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar93.anc" start="1623" end="1626" sStart="null" offset="0" sid="null" wn="4" wnkey="meet%2:34:00::" annotator="veweser" text="Of the 238 patients with synovitis of recent onset in the cohort, 106 (45%) &lt;b&gt;met&lt;/b&gt; RA criteria, 102 (96%) of whom &lt;b&gt;met&lt;/b&gt; the criteria on their initial visit." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar93.anc" start="1623" end="1626" sStart="null" offset="0" sid="null" wn="4 5 6" wnkey="null" annotator="tofox" text="Of the 238 patients with synovitis of recent onset in the cohort, 106 (45%) &lt;b&gt;met&lt;/b&gt; RA criteria, 102 (96%) of whom &lt;b&gt;met&lt;/b&gt; the criteria on their initial visit." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar93.anc" start="1623" end="1626" sStart="null" offset="0" sid="null" wn="5" wnkey="meet%2:42:01::" annotator="comcgeetubb" text="Of the 238 patients with synovitis of recent onset in the cohort, 106 (45%) &lt;b&gt;met&lt;/b&gt; RA criteria, 102 (96%) of whom &lt;b&gt;met&lt;/b&gt; the criteria on their initial visit." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar93.anc" start="1623" end="1626" sStart="null" offset="0" sid="null" wn="4" wnkey="meet%2:34:00::" annotator="cgozo" text="Of the 238 patients with synovitis of recent onset in the cohort, 106 (45%) &lt;b&gt;met&lt;/b&gt; RA criteria, 102 (96%) of whom &lt;b&gt;met&lt;/b&gt; the criteria on their initial visit." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar93.anc" start="1623" end="1626" sStart="null" offset="0" sid="null" wn="5" wnkey="meet%2:42:01::" annotator="brubin" text="Of the 238 patients with synovitis of recent onset in the cohort, 106 (45%) &lt;b&gt;met&lt;/b&gt; RA criteria, 102 (96%) of whom &lt;b&gt;met&lt;/b&gt; the criteria on their initial visit." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="27940" end="27945" sStart="null" offset="119" sid="r9.level.n.0574" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="We examined a spectrum of potential RA severity indicators including the number of swollen joints, CRP level, and presence of early radiographic erosions." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/ar93.anc" start="478" end="483" sStart="null" offset="0" sid="null" wn="3" wnkey="know%2:31:02::" annotator="carichter" text="To help address these questions, a spectrum of autoantibodies &lt;b&gt;known&lt;/b&gt; to be associated with RA in a cohort of patients with early synovitis was evaluated." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="25924" end="25929" sStart="null" offset="91" sid="r10.find.v.0964" wn="4" wnkey="find%2:32:00::" annotator="brubin" text="Of note, a large epidemiologic study of patients with early inflammatory arthritis found that the proportion of patients who met the ACR criteria increased if the criteria were applied cumulatively over a 5 year period [ 29]." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="29261" end="29267" sStart="null" offset="63" sid="r10.common.j.0598" wn="2" wnkey="common%3:00:01::" annotator="anfahmy" text="AFA, AKA, and APF have been proposed to all identify a common antigen present in the skin protein (pro)filaggrin [ 1, 3, 4, 5, 6]." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="25708" end="25719" sStart="null" offset="118" sid="r11.combination.n.0322" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="In particular, we sought to determine how sensitive and specific each of the antibodies, alone and in combination, were for early RA." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="6656" end="6663" sStart="null" offset="101" sid="r9.appear.v.0293" wn="1" wnkey="appear%2:39:00::" annotator="veweser" text="A potential explanation for this may relate to the demonstration that citrulline appears to be an essential constituent of the antigenic determinants recognized by AKA, APF, and AFA." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="19982" end="19989" sStart="null" offset="7" sid="r11.absence.n.0886" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="In the absence of RF, the presence of one or more of these antibodies carried a sensitivity of only 31% for RF- RA, with anti-Sa being the most specific at 98%." />
    <s path="[OANC]/data/written_2/technical/biomed/ar93.anc" start="3101" end="3108" sStart="null" offset="7" sid="r11.absence.n.0561" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="In the absence of RF, the presence of one or more of these antibodies carried a sensitivity of only 31% for RF- RA, with anti-Sa being the most specific at 98%." />
  </sentences>
</list>